Viewing Study NCT00321620


Ignite Creation Date: 2025-12-25 @ 4:09 AM
Ignite Modification Date: 2026-01-22 @ 7:40 AM
Study NCT ID: NCT00321620
Status: COMPLETED
Last Update Posted: 2018-08-29
First Post: 2006-05-02
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Men With Hormone-refractory Prostate Cancer
Sponsor: Amgen
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Bone Metastases View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Bone metastases View
None Hormone-refractory prostate cancer View
None Skeletal View
None Fractures View
None Compressions View
None Bisphosphonates View